Does Congress Beat the Stock Market? What the Research Actually Shows

"Congress beats the market" has become conventional wisdom in retail investing circles. But the reality is more nuanced — and the nuance matters if you're trying to use congressional trade data as an investment signal.

Here's what the research actually shows.

The Original Studies

The claim originates from two influential academic papers:

Ziobrowski et al. (2004) — "Abnormal Returns From the Common Stock Investments of the U.S. Senate" Published in the Journal of Financial and Quantitative Analysis. Analyzed Senate stock portfolios from 1993–1998. Finding: senators outperformed the market by approximately 10% annually on their disclosed trades.

Ziobrowski et al. (2011) — "Abnormal Returns From the Common Stock Investments of Members of the U.S. House of Representatives" The follow-up study covering House members from 1985–2001. Finding: Representatives outperformed by approximately 6% annually.

Both studies used portfolio simulation methodology — tracking disclosed transactions and computing returns as if an investor had copied the trades.

These papers are the foundation of the "Congress beats the market" claim.

What Happened After the STOCK Act

The STOCK Act passed in 2012, partly in response to public outrage following coverage of these studies (and the 60 Minutes segment that went viral in 2011).

The law required faster disclosure and explicitly prohibited trading on legislative MNPI. What happened to congressional outperformance after it passed?

The post-STOCK Act data shows significantly reduced abnormal returns. Multiple subsequent studies found that the outperformance documented in the pre-2012 era largely disappeared or became statistically insignificant after the law's passage.

Two interpretations:

1. The STOCK Act worked — members stopped trading on privileged information
2. The faster disclosure requirement made the trades more visible, deterring information-adjacent trading even without criminal prosecution

Both are probably partially true. The enforcement record (near-zero prosecutions) doesn't support the first explanation fully. The deterrence explanation is more consistent with the behavioral response to greater scrutiny.

But the Outperformance Didn't Disappear Entirely

Post-STOCK Act studies still find pockets of statistically significant outperformance. The key finding: it's concentrated.

The abnormal returns in the post-2012 era are not evenly distributed across all members. They're concentrated in:

High-committee-overlap trades: Trades where the member's committee assignments directly relate to the sector traded. Armed Services members buying defense contractors. HELP Committee members trading pharma. Intelligence Committee members in tech.

Large-amount trades: The $500K–$1M+ range shows higher abnormal returns than small trades. This makes intuitive sense — if you have a high-conviction information edge, you size the position accordingly.

Clustered trades: When multiple members from the same committee trade the same stock within a short window, subsequent returns are higher than single-member trades in the same name.

Early disclosures: Paradoxically, trades disclosed quickly (within 5–10 days) show slightly higher returns than trades disclosed near the 45-day limit. One theory: members who are more confident in a trade's legitimacy disclose sooner; members who delay may be aware that the timing looks suspicious.

The "Pelosi Effect" Problem

A significant portion of post-2012 congressional trading returns are attributable to a handful of members — and particularly to Nancy Pelosi's disclosed trades.

From 2020–2023, Pelosi's disclosed tech positions generated substantial returns. NVDA purchases before AI policy developments, GOOG positions around regulatory shifts, AAPL trades around supply chain legislation. If you remove Pelosi from the dataset, the aggregate congressional outperformance shrinks substantially.

This is a problem for broad "invest like Congress" strategies: the signal is driven by a small number of members with unusually high intent scores, not by Congress as a whole.

The average congressional trade is probably not information-adjacent. It's routine investing, index-like exposure, and spousal portfolios that have nothing to do with legislative access.

What This Means for Your Strategy

The research picture suggests:

Don't try to copy all of Congress. The NANC and KRUZ ETFs make this mistake — they replicate all disclosed trades, which dilutes the signal to something close to market-rate returns with higher fees.

Focus on committee-adjacent trades. The outperformance that does exist is concentrated in trades where there's a plausible information overlap between the member's committee assignments and the traded sector.

Filter by intent metrics. A trade scored 85+ on Cloakroom's AI Intent model has the structural characteristics associated with the outperforming subset of congressional trades — committee overlap, timing relative to legislative events, and disclosure lag patterns that suggest the trade may not be entirely routine.

Act on alerts, not archives. The outperformance in historical data assumed you could replicate trades at or near the disclosed price. In practice, the faster you see the disclosure, the closer to that price you can act. Real-time alerts matter.

The Bottom Line

Does Congress beat the market? On average, marginally and inconsistently. In specific cases — high-committee-overlap trades by high-activity members in information-adjacent sectors — yes, and more substantially.

The "Congress beats the market" headline is technically supported by older research but overstated as a broad claim. The more accurate statement: a subset of congressional trades, identifiable by committee context and timing, has historically generated above-market returns.

That subset is what's worth tracking. Cloakroom is built to surface exactly those trades.

---

Academic citations: Ziobrowski et al. (2004), Journal of Financial and Quantitative Analysis; Ziobrowski et al. (2011), Business and Politics. This post is not investment advice.